Free Trial
NASDAQ:MASI

Masimo (MASI) Stock Price, News & Analysis

Masimo logo
$145.66 +3.12 (+2.19%)
As of 03:20 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Masimo Stock (NASDAQ:MASI)

Advanced

Key Stats

Today's Range
$140.89
$145.84
50-Day Range
$136.77
$164.62
52-Week Range
$131.60
$194.88
Volume
332,776 shs
Average Volume
637,540 shs
Market Capitalization
$7.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$194.60
Consensus Rating
Buy

Company Overview

Masimo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
88th Percentile Overall Score

MASI MarketRank™: 

Masimo scored higher than 88% of companies evaluated by MarketBeat, and ranked 117th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Masimo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Masimo has a consensus price target of $194.60, representing about 33.6% upside from its current price of $145.66.

  • Amount of Analyst Coverage

    Masimo has only been the subject of 3 research reports in the past 90 days.

  • Read more about Masimo's stock forecast and price target.
  • Earnings Growth

    Earnings for Masimo are expected to grow by 12.93% in the coming year, from $4.10 to $4.63 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Masimo is -17.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Masimo is -17.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Masimo has a P/B Ratio of 7.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Masimo's valuation and earnings.
  • Percentage of Shares Shorted

    7.29% of the float of Masimo has been sold short.
  • Short Interest Ratio / Days to Cover

    Masimo has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Masimo has recently increased by 5.08%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Masimo does not currently pay a dividend.

  • Dividend Growth

    Masimo does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.29% of the float of Masimo has been sold short.
  • Short Interest Ratio / Days to Cover

    Masimo has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Masimo has recently increased by 5.08%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Masimo has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Masimo this week, compared to 12 articles on an average week.
  • Search Interest

    8 people have searched for MASI on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Masimo to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Masimo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $452,975.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 9.70% of the stock of Masimo is held by insiders.

  • Percentage Held by Institutions

    85.96% of the stock of Masimo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Masimo's insider trading history.
Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MASI Stock News Headlines

College grad makes $64,000 a month
A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took dozens of technology and finance experts, including one PhD astrophysicist, and $4 million in total research costs). In a multi-year backtest, this breakthrough beat stocks, bonds, gold... even Warren Buffett.tc pixel
Masimo Corporation (MASI): A Bull Case Theory
Masimo (NASDAQ:MASI) Upgraded by Wall Street Zen to Buy Rating
Masimo Corporation (MASI): A Bull Case Theory 
See More Headlines

MASI Stock Analysis - Frequently Asked Questions

Masimo's stock was trading at $165.30 at the beginning of 2025. Since then, MASI stock has decreased by 11.9% and is now trading at $145.6550.

Masimo Corporation (NASDAQ:MASI) announced its earnings results on Tuesday, August, 5th. The medical equipment provider reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.22 by $0.11. The company's revenue for the quarter was up 7.7% compared to the same quarter last year.
Read the conference call transcript
.

Masimo's top institutional investors include GAMMA Investing LLC. Insiders that own company stock include Joe E Kiani, Bilal Muhsin, Craig B Reynolds, Michelle Brennan and William R Jellison.
View institutional ownership trends
.

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Masimo investors own include NVIDIA (NVDA), Meta Platforms (META), CrowdStrike (CRWD), Broadcom (AVGO), Adobe (ADBE), ServiceNow (NOW) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/05/2025
Today
10/02/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:MASI
CIK
937556
Employees
5,600
Year Founded
1989

Price Target and Rating

High Price Target
$210.00
Low Price Target
$185.00
Potential Upside/Downside
+36.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($8.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
34.77
P/E Growth
N/A
Net Income
-$304.90 million
Net Margins
-24.85%
Pretax Margin
-13.73%
Return on Equity
26.54%
Return on Assets
11.49%

Debt

Debt-to-Equity Ratio
0.57
Current Ratio
2.14
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$2.09 billion
Price / Sales
3.70
Cash Flow
$6.17 per share
Price / Cash Flow
23.10
Book Value
$19.50 per share
Price / Book
7.31

Miscellaneous

Outstanding Shares
54,330,000
Free Float
49,055,000
Market Cap
$7.74 billion
Optionable
Optionable
Beta
1.28

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:MASI) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners